Aye ILMH, Moraitis AA, Stanislaus D, Charnock-Jones DS and Smith GCS (2018). Retosiban prevents stretch-induced human myometrial contractility and delays labor in Cynomolgus monkeys. J. Clin. Endocrinol. Metab. 103(3): 1056-1067

Bacon WA, Hamilton RS, Yu Z, Kieckbusch J, Hawkes D, Krzak AM, Abell C, Colucci F and Charnock-Jones DS (2018). Single-cell analysis identifies thymic maturation delay in growth-restricted neonatal mice. Front. Immunol. 9: 2523

Beeson JH, Blackmore HL, Carr SK, Dearden L, Duque-Guimarães DE, Kusinski LC, Pantaleão LC, Pinnock AG, Aiken CE, Giussani DA, Fernandez-Twinn DS and Ozanne SE (2018). Maternal exercise intervention in obese pregnancy improves the cardiovascular health of the adult male offspring. Mol. Metab. 16: 35-44

de Goffau MC, Lager S, Salter SJ, Wagner J, Kronbichler A, Charnock-Jones DS, Peacock SJ, Smith GCS and Parkhill J (2018). Recognizing the reagent microbiome. Nat. Microbiol. 3(8): 851-853.
Filipovic I, Chiossone L, Vacca P, Hamilton RS, Ingegnere T, Doisne JM, Hawkes DA, Mingari MC, Sharkey AM, Moretta L and Colucci F (2018). Molecular definition of group 1 innate lymphoid cells in the mouse uterus. Nat. Commun. 9(1): 4492

Flint TR, Jones JO, Ferrer M, Colucci F and Janowitz T (2018). A comparative analysis of immune privilege in pregnancy and cancer in the context of checkpoint blockade immunotherapy. Semin. Oncol. 45(3): 170-175

Gaccioli F, Aye ILMH, Sovio U, Charnock-Jones DS and Smith GCS (2018). Screening for fetal growth restriction using fetal biometry combined with maternal biomarkers. Am. J. Obstet. Gynecol. 218(2S): S725-S737

Gaccioli F, Sovio U, Cook E, Hund M, Charnock-Jones DS and Smith GCS (2018). Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study. Lancet Child Adolesc. Health 2(8): 569-581

Gong S, Johnson MD, Dopierala J, Gaccioli F, Sovio U, Constância M, Smith GC and Charnock-Jones DS (2018). Genome-wide oxidative bisulfite sequencing identifies sex-specific methylation differences in the human placenta. Epigenetics 13(3): 228-239

Gong S, Sovio U, Aye IL, Gaccioli F, Dopierala J, Johnson MD, Wood AM, Cook E, Jenkins BJ, Koulman A, Casero RA Jr, Constância M, Charnock-Jones DS and Smith GC (2018). Placental polyamine metabolism differs by fetal sex, fetal growth restriction, and preeclampsia. JCI Insight 3(13).pii: 120723

Howard SR, Guasti L, Poliandri A, David A, Cabrera CP, Barnes MR, Wehkalampi K, O’Rahilly S, Aiken CE, Coll AP, Ma M, Rimmington D, Yeo GSH and Dunkel L (2018). Contributions of function-altering variants in Ggnes implicated in pubertal timing and body mass for self-limited delayed puberty. J. Clin. Endocrinol. Metab. 103(2): 649-659

Huhn O, Chazara O, Ivarsson MA, Retière C, Venkatesan TC, Norman PJ, Hilton HG, Jayaraman J, Traherne JA, Trowsdale J, Ito M, Kling C, Parham P, Ghadially H, Moffett A, Sharkey AM and Colucci F (2018). High-resolution genetic and phenotypic analysis of KIR2DL1 alleles and their association with pre-eclampsia. J. Immunol. 201(9): 2593-2601

Lager S, de Goffau MC, Sovio U, Peacock SJ, Parkhill J, Charnock-Jones DS and Smith GCS (2018). Detecting eukaryotic microbiota with single-cell sensitivity in human tissue. Microbiome 6(1): 151

Loche E, Blackmore HL, Carpenter AA, Beeson JH, Pinnock A, Ashmore TJ, Aiken CE, de Almeida-Faria J, Schoonejans JM, Giussani DA, Fernandez-Twinn DS and Ozanne SE (2018). Maternal diet-induced obesity programmes cardiac dysfunction in male mice independently of post-weaning diet. Cardiovasc. Res. 114(10): 1372-1384

Misra MK, Augusto DG, Martin GM, Nemat-Gorgani N, Sauter J, Hofmann JA, Traherne JA, González-Quezada B, Gorodezky C, Bultitude WP, Marin W, Vierra-Green C, Anderson KM, Balas A, Caro-Oleas JL, Cisneros E, Colucci F, Dandekar R, Elfishawi SM, Fernández-Viña MA, Fouda M, González-Fernández R, Große A, Herrero-Mata MJ, Hollenbach SQ, Marsh SGE, Mentzer A, Middleton D, Moffett A, Moreno-Hidalgo MA, Mossallam GI, Nakimuli A, Oksenberg JR, Oppenheimer SJ, Parham P, Petzl-Erler ML, Planelles D, Sánchez-García F, Sánchez-Gordo F, Schmidt AH, Trowsdale J, Vargas LB, Vicario JL, Vilches C, Norman PJ and Hollenbach JA (2018). Report from the Killer-cell Immunoglobulin-like Receptors (KIR) component of the 17th International HLA and Immunogenetics Workshop. Hum. Immunol. 79(12): 825-833

Pritchard N, Kaitu’u-Lino TJ, Gong S, Dopierala J, Smith GCS, Charnock-Jones DS and Tong S (2018). ELABELA/APELA levels are not decreased in the maternal circulation or placenta among women with preeclampsia. Am. J. Pathol. 188(8): 1749-1753

Rätsep MT, Moore SD, Jafri S, Mitchell M, Brady HJM, Mandelboim O, Southwood M, Morrell NW, Colucci F and Ormiston ML (2018). Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency. Am. J. Physiol. Lung Cell Mol. Physiol. 315(6): L977-L990

Salavati N, Gordijn SJ, Sovio U, Zill-E-Huma R, Gebril A, Charnock-Jones DS, Scherjon SA and Smith GCS (2018). Birth weight to placenta weight ratio and its relationship to ultrasonic measurements, maternal and neonatal morbidity: A prospective cohort study of nulliparous women. Placenta 63: 45-52

Smith GCS (2018) Universal screening for foetal growth restriction. Best Pract. Res. Clin. Obstet. Gynaecol. 49: 16-28

Smith GCS (2018). Author’s reply re: Should we implement universal screening with late pregnancy ultrasound to prevent stillbirth? BJOG 125(7): 908-909

Smith GCS (2018). The STRIDER trial: one step forward, one step back. Lancet Child Adolesc. Health. 2(2): 80-81

Sovio U and Smith GCS (2018). Blinded ultrasound fetal biometry at 36 weeks and risk of emergency Cesarean delivery in a prospective cohort study of low-risk nulliparous women. Ultrasound Obstet. Gynecol. 52(1): 78-86

Sovio U and Smith GCS (2018). Screening performance of consensus definition of fetal growth restriction inappropriately evaluated – Authors’ reply. Lancet Child Adolesc. Health 2(9): e23

Sovio U and Smith GCS (2018). The effect of customization and use of a fetal growth standard on the association between birthweight percentile and adverse perinatal outcome. Am. J. Obstet. Gynecol. 218(2S): S738-S744

Sovio U, Moraitis AA, Wong HS and Smith GCS (2018). Universal vs selective ultrasonography to screen for large-for-gestational-age infants and associated morbidity. Ultrasound. Obstet. Gynecol. 51(6): 783-791

Sovio U and Smith GCS (2018). Reply to: The effect of customization and use of a fetal growth standard on the association between birthweight percentile and adverse perinatal outcome: methodologic issues. Am. J. Obstet. Gynecol. 218(6): 629-630

Tarry-Adkins JL, Aiken CE, Ashmore TJ and Ozanne SE (2018). Insulin-signalling dysregulation and inflammation is programmed trans-generationally in a female rat model of poor maternal nutrition. Sci. Rep. 8(1): 4014